Clinical trials for Acute leukemia
61 currently recruiting clinical trials
Looking for clinical trials?
Clinical trial search is a complex process, with countless criteria to consider. Our AI assistant navigates this complexity with precise, expert-level analysis of the most relevant trials based on your medical profile. Our database is fully up to date, so you see only actively recruiting sites. It's fast and easy:
- Create your account
- Copy-paste your latest medical report
- Our AI-based assistant does the rest for you
Whether you are a patient or a doctor, create an account to find and apply for the most relevant clinical trials:
Phase 2
Acute leukemia
#NCT05917405
Acute myeloid leukemia (AML)
> 60 ml/min
50-60 ml/min
None
1
Systemic Treatment-Naive
Chemotherapy
20 recruiting sites
Hôpital universitaire de Nantes
Phase 1 / Phase 2
Acute leukemia
#NCT04256317
Phase 1 et 2 : Thérapie combinée
Acute myeloid leukemia (AML)
None
Treated / Controled
None
Systemic Treatment-Naive
Chemotherapy
Targeted therapy
Car-T
3 recruiting sites
Taiho Oncology
Phase 1 / Phase 2
Lymphoma
CLL & Richter's syndrome
Acute leukemia
Myelodysplastic Syndromes (MDS) and Myeloproliferative Neoplasms (MPN)
#NCT07220616
#2025-522595-87-00
None
Treated / Controled
1
2
3 or more
Systemic Treatment-Naive
Allogeneic stem cell transplant
1 recruiting site
Daiichi Sankyo
Phase 1 / Phase 2
Acute leukemia
#NCT04988555
#2022-502741-10-00
Phase 1, bras A, B, E et F
Acute lymphoblastic leukemia (ALL)
Acute myeloid leukemia (AML)
Other acute leukemia
None
Treated / Controled
> 60 ml/min
50-60 ml/min
KMT2A
MLL fusions
NPM1
1
2
3 or more
Systemic Treatment-Naive
8 recruiting sites
Sumitomo Pharma America, Inc.
Phase 1 / Phase 2
Acute leukemia
#NCT05601726
Acute myeloid leukemia (AML)
2
3 or more
Systemic Treatment-Naive
3 recruiting sites
Advanced BioDesign
Phase 1 / Phase 2
Acute leukemia
#NCT04771130
#2021-003285-12
Parties 1, 2 et 3 cohortes LAM
Acute myeloid leukemia (AML)
None
> 60 ml/min
50-60 ml/min
None
Systemic Treatment-Naive
BCR-ABL
Targeted therapy
3 recruiting sites
BeOne Medecines
Phase 1 / Phase 2
Acute leukemia
#NCT04811560
Phase 2
Acute myeloid leukemia (AML)
None
Treated / Controled
KMT2A
NPM1
1
2
3 or more
Systemic Treatment-Naive
11 recruiting sites
Janssen
Phase 1 / Phase 2
Acute leukemia
#NCT04811560
Phase 1
None
Treated / Controled
Other mutation
KMT2A
NPM1
NUP214
1
2
3 or more
Systemic Treatment-Naive
11 recruiting sites
Janssen
Phase 1 / Phase 2
Acute leukemia
#NCT06356922
Acute lymphoblastic leukemia (ALL)
Acute myeloid leukemia (AML)
None
> 60 ml/min
50-60 ml/min
1
2
3 or more
Systemic Treatment-Naive
4 recruiting sites
Hôpital universitaire de Nantes
Phase 1 / Phase 2
Acute leukemia
#NCT04988555
[Horizen-1 Étude de phase 1/2 de l'Enzomenib (DSP-5336) chez les patients atteints de leucémie aiguë
Phase 1, Bras L, M et N
Acute myeloid leukemia (AML)
None
Treated / Controled
> 60 ml/min
50-60 ml/min
KMT2A
NPM1
None
Systemic Treatment-Naive
8 recruiting sites
Sumitomo Pharma America, Inc.